Health
Insilico Medicine AI-powered COVIDomic for COVID-19 Research – insideHPC
Santa Clara, CA – Insilico Medicine, a leader in artificial intelligence for drug discovery and development, announced the launch of a system for COVID-19 basic and clinical research. COVIDomic is a foundational technology that enables scientists to use anony…
Santa Clara, CA Insilico Medicine, a leader in artificial intelligence for drug discovery and development, announced the launch of a system for COVID-19 basic and clinical research. COVIDomic is a foundational technology that enables scientists to use anonymized patient data to integrate with a variety of existing data sets. Bioinformatics and AI tools can then be applied in many ways, starting with better stratifying COVID-19 patients, understanding the disease trajectory and identifying releva…
